 | This article needs additional citations for verification .(January 2017) |
The European Association for the Study of Diabetes (EASD) is a scientific association founded in Montecatini Terme, Italy in 1965 with Joseph Hoet as Founding President. [1] The aims of the association are to encourage and support research in the field of diabetes, the rapid diffusion of acquired knowledge in that field, and to facilitate its application. [2]
The association is based on individual membership and embraces scientists, physicians, laboratory workers, nurses and students internationally who are interested in diabetes and related subjects. An Active Member is an individual holding a medical degree or a scientific worker with an academic degree who has paid the current annual membership fee. Members are entitled to vote at the general assembly, which is held during the annual meeting, and are eligible for election to the council and to the executive committee. Membership also provides the possibility of attending the annual meetings of the association at a considerably reduced registration fee. Active members receive monthly the official journal of the association, Diabetologia, which publishes articles on clinical and experimental diabetes and metabolism. In addition there are rapid communications and review articles on selected topics of current interest by leading experts in the field.
The active membership of the association currently numbers more than 3000 individuals from over 100 countries. The association also bestows honorary membership on any individual whose medical or scientific contribution to diabetes research has been outstanding; the first honorary member of the association was Charles Best.
The association is governed by a General Assembly (members) and an Executive Committee of 5-9 members which is elected by the General Assembly. [3]
The annual meeting of the association is held in a different European city each year. It attracts 17,000–18,000 participants from over 100 countries worldwide. Abstracts are invited from members and non-members. All abstracts are anonymously reviewed by a programme committee, chaired by the honorary secretary. The EASD was one of the first international associations to introduce the anonymous review of abstracts. The scientific programme of the meeting, providing titles of the lectures and symposia, is made available online at an early stage, and, once confirmed, the speakers' names are made available about 6–8 weeks before the start of the meeting. All abstracts accepted for presentation can be accessed online via the online programme. A search function assists the visitor in finding abstracts in their field of interest. Since 2012 the EASD Virtual Meeting presents posters and talks from the conference online free of charge.
To assist the participation of young presenting authors, the association has established a travel fund from which over 100 awards are made available for each annual meeting.
The association awards four major prizes annually: the Camillo Golgi Prize, the Claude Bernard Medal, the Minkowski Prize, the Albert Renold Prize Lecture and the EASD-Novo Nordisk Foundation Diabetes Prize for Excellence. The recipients of these prizes deliver a lecture at the Annual Meeting.
The association holds annually an EASD Scientists Training Course and a Robert Turner Clinical Research Course to attract new talent to diabetes research in different centres throughout the world. Nominations are invited from EASD members. Together with the Juvenile Diabetes Research Foundation (JDRF), EASD organises a yearly workshop in Oxford, United Kingdom, where 20 seniors and fellows come together.
The association organises both European and Extra-European postgraduate courses.
To date EASD has held postgraduate education courses in Albania Austria Azerbaijan Brazil Bulgaria Cameroon China Croatia Czech Republic Denmark Ethiopia France Georgia Germany Greece Hungary India Iran Ireland Israel Italy Kazakhstan Kenya Lithuania Macedonia Malta Nepal Oman Palestine Panama Poland Portugal Romania Russia Serbia South Africa Spain Sri Lanka Tanzania Turkey UAE UK Ukraine Uzbekistan Vietnam
The EASD Post Graduate Education Committee (PGEC) is active in organising workshops and courses for clinicians and educators.
The association has the following Study Groups:
Artificial Insulin Delivery System (AIDPIT); Diabetes and Cancer Study Group; Diabetes Education Study Group (DESG); Diabetic Pregnancy Study Group (DPSG); Non-alcoholic fatty liver disease (NAFLD); Diabetes Neuropathy Study Group (NEURODIAB); EASD Eye Complication Study Group (EASDEC); European Diabetic Nephropathy Study Group (EDNSG); Incretin Study Group; EASD Islet Study Group; European Diabetes Epidemiology Group (EDEG); Diabetes and Nutrition Study Group (DNSG); Psychosocial Aspects of Diabetes (PSAD); Diabetic Foot Study Group (DFSG); EASD Study Group on Primary Care Research in Diabetology (PCCD); Genetics of Diabetes Study Group; Diabetes and Cardiovascular Disease Study Group (D&CVD).
The European Association for the Study of Diabetes recommends people with diabetes to consume a healthy diet with fruit, nuts, seeds, vegetables and whole grains while minimising the consumption of red and processed meat, refined grains, sodium and sugar-sweetened beverages. [4]
In 1999, the EASD increased its commitment to stimulate diabetes research in Europe by creating the European Foundation for the Study of Diabetes (EFSD). The foundation is closely related to the EASD; it is governed exclusively by the Executive Committee of the EASD, which itself is under the close supervision of the EASD General Assembly. EFSD operates on a strictly non-profit basis under the control of the relevant authorities for charity and taxation.
The EASD, as an academic non-profit association, benefits from the possibilities offered by the legal status of its Foundation to advance diabetes research by various methods. Since its inception, EFSD has committed an amount approaching Euro 100 million to diabetes research in Europe by various funding means. In the last five years, the foundation has become a significant European funding agency for diabetes research, and is continually striving to enhance awareness in Europe of the severity and magnitude of this devastating disease.
Most programmes offer funding for researchers working in Europe and associated countries, but some are open to scientists from all over the world. All applications are subject to peer review by a panel of leading experts in the field.
The International Epidemiological Association (IEA) is a worldwide association with more than 2000 members in over 100 different countries, who follow the aims of the association to facilitate communication amongst those engaged in research and teaching of epidemiology throughout the world, and to encourage its use in all fields of health including social, community and preventative medicine. These aims are achieved by holding scientific meetings and seminars, by publication of journals, reports, translations of books, by contact amongst members and by other activities consistent with these aims. Members are accepted without regard to race, religion, sex, political affiliation or country of origin.
The Royal Academies for Science and the Arts of Belgium (RASAB) is a non-governmental association that promotes and organises science and the arts in Belgium by coordinating the national and international activities of its constituent academies such as the National Scientific Committees and the representation of Belgium in international scientific organisations.
Oskar Minkowski was a German physician and physiologist who held a professorship at the University of Breslau and is most famous for his research on diabetes. He was the brother of the mathematician Hermann Minkowski and father of astrophysicist Rudolph Minkowski.
The Daiwa Anglo-Japanese Foundation is a United Kingdom-based charity established in 1988 to support closer links between Britain and Japan. It was founded with a benefaction from Daiwa Securities Co Ltd.
The European Association of Urology (EAU) is a non-profit organisation committed to the representation of urology professionals worldwide. All active urology professionals, including urology nurses, are eligible for membership of the EAU.
The European College of Neuropsychopharmacology (ECNP) is a pan-European, non-profit scientific association that serves as a platform to exchange and promote research in the field of neuropsychopharmacology. The ECNP “is committed to ensuring that advances in the understanding of brain function and human behaviour are translated into better treatments and enhanced public health”. The ECNP organises a number of activities to achieve this aim, such as a yearly congress, workshops, seminars, New Frontiers Meetings, publications, awards, supported talks and much more.
Bernhard Ludvik is a Specialist in Internal Medicine, board certified in Endocrinology and Metabolism. He is currently an Associate Professor of Medicine at the Medical University of Vienna. He serves as the Deputy Head of the Division of Endocrinology and Metabolism at the General Hospital Vienna.
The Széchenyi István College for Advanced Studies is a distinctive member of the college-movement, consisting of several similar colleges, operating in the Hungarian system of higher education. The college was founded in 1987 as a self-organised, autonomous institution by the students of the Karl Marx University of Economic Sciences, based on the model of the existing colleges. Its main goal is to enable its members to achieve a high level of proficiency in economics and social sciences, and to master their academic skills in a democratic, deeply communal environment. Its members are students of universities of Budapest, mainly studying at the Corvinus University of Budapest and the Eötvös Loránd University. Besides the academic benefits, the college also offers its members accommodation. Based on its two-decade-long experience in student association activities, the college actively contributes to the shaping of university public life.
Juleen R. Zierath is an American-Swedish biologist. Her research focuses on the cellular mechanisms that correspond to the development of insulin resistance in Type II diabetes. Her other research areas look at exercise-mediated effects on skeletal muscle glucose metabolism and gene expression.
The British Society for Research on Ageing (BSRA) is a scientific society which promotes research to understand the causes and effects of the ageing process. The BSRA encourages publication and public understanding of ageing research and holds an annual scientific meeting. Many notable scientists with an interest in ageing are either past or current members of the organisation, which has exerted a marked influence on ageing research within the United Kingdom and internationally.
The Craniofacial Society of Great Britain and Ireland (CFSGBI), commonly known as the Craniofacial Society, is a professional organisation and charity dedicated to the study of cleft lip and palate and other craniofacial anomalies based at the Royal College of Surgeons of England in London in the United Kingdom. The Society first convened in 1970 and continued to meet on an ad hoc basis, leading to its formal constitutional establishment in 1985. The Society has since grown in terms of membership and stature and has developed to become the leading professional organisation for cleft health care professionals in the United Kingdom and Ireland.
Matthias H. Tschöp is a German physician and scientist. He is the chief executive officer and scientific director of Helmholtz Zentrum München, German Research Center for Environmental Health. He is also Alexander von Humboldt Professor and chair of metabolic diseases at Technical University of Munich and serves as an adjunct professor at Yale University.
EFSD may refer to:
Albert Ernst Renold was a Swiss physician and clinical biochemist noted for his extensive research on diabetes. In 1986 he was awarded the King Faisal International Prize in Medicine for contributions to the understanding of diabetes.
Miriam Cnop is a Belgian researcher and physician specializing in diabetology. She is Professor of Medicine at Université Libre de Bruxelles and Clinical Director of Erasmus Hospital’s Endocrinology Department. Her work centered on type 2 diabetes, in particular mechanisms of lipotoxicity using human islets of Langerhans and human induced pluripotent stem cell-derived β Cells. She is an associate member of the Royal Academy of Medicine of Belgium. In 2013, her work was awarded the Oskar Minkowski prize from the European Association for the Study of Diabetes.
Roy Taylor is a physician, diabetologist, and author who is currently the Director of Newcastle Magnetic Resonance Centre. His Scopus h-index is 54.
Brian M. Frier is a Scottish physician, diabetologist, clinical scientist, and an Honorary Professor of Diabetes at the University of Edinburgh. He is best known for his many scientific contributions to the pathophysiological understanding of hypoglycemia, a common adverse effect of insulin therapy in diabetic patients whose societal impact has deserved increasing media attention worldwide. His honors include the R.D. Lawrence Lecture of the British Diabetic Association in 1986, the Banting Memorial Lecture at Diabetes UK in 2009, the Camillo Golgi Prize and lecture at the 53rd annual EASD conference in 2017, and the Michael Somogyi Award from the Hungarian Diabetes Association in 2004. Frier is a science book author and editor, and a science journal Chief editor. He is also regarded as an authority on the field of driving and diabetes. In 2023, Frier was accorded Honorary Life Membership by the European Association of Diabetes.
Anna L Gloyn is a geneticist, who is Professor of Pediatrics (Endocrinology) and Genetics at Stanford University. She was the recipient of the Minkowski Prize in 2014 for her research into causal mechanisms of diabetes pathogenesis. Her work has contributed to improved treatment options for people with rare forms of diabetes and helped advance our understanding of type 2 diabetes.
Anne Peters is a endocrinologist, diabetes expert, and professor of clinical medicine at the Keck School of Medicine of USC. She runs diabetes centers in well-served Beverly Hills and under-resourced East Los Angeles. She teaches physicians and people with diabetes around the world how to better treat the condition, through lifestyle, medications and technology.
Vijay Viswanathan is a diabetologist from India who is the chief diabetologist at M.V. Hospital for Diabetes based in Chennai. He is also the President of Prof. M. Viswanathan Diabetes Research Centre and the first Asian President of D-Foot International, a non-profit organization based in Belgium. Viswanathan has published over 543 research papers, in publications including the National Library of Medicine, on topics such as primary prevention and management of diabetes, diabetic foot and prevention of amputation, diabetic nephropathy, socio-economics of diabetes care and Pulmonary TB and diabetes.
| International | |
|---|---|
| National | |
| Other | |
